纤溶酶联合血塞通治疗急性脑梗死临床探讨
2015-11-13郭好战,李红员,夏东亚
纤溶酶联合血塞通治疗急性脑梗死临床探讨
郭好战1,李红员2,夏东亚3
1.河南省永城市人民医院神经内科,河南永城476600;2.河南省永城市人民医院消化内科,河南永城476600;
3.河南省永城市人民医院心血管内科,河南永城476600
[摘要]目的探讨以纤溶酶联合血塞通对急性脑梗死进行治疗所得到临床效果。方法整群选择2014年4月—2015年3月曾在该院接受治疗的急性脑梗死患者108例,以随机方式分为观察组与对照组,对照组中患者选择血塞通进行治疗,观察组中患者在对照组基础上联合纤溶酶进行治疗。结果对照组中患者临床有效率为74.1%,观察组中患者临床总有效率能够达到92.6%;观察组中患者治疗前后评分平均为(26.6±8.6)分、(8.4±2.4)分,对照组中患者治疗前后评分分别为平均(26.8± 8.8)分、(14.5±3.5)分;观察组患者治疗前后神经功能缺损程度评分与对照组相比明显较优秀;两组患者均无严重不良反应发生。结论以纤溶酶联合血塞通对急性脑梗死进行治疗能够得到较理想临床效果,可有效改善患者临床症状,增强患者神经功能,并且不会发生严重不良反应。
[关键词]急性脑梗死;纤溶酶;血塞通
[中图分类号]R59
[文献标识码]A
[文章编号]1674-0742(2015)10(a)-0126-02
[作者简介]郭好战(1986.06-),男,河南永城人,本科,主治医师,研究方向:神经内科。
收稿日期:(2015-07-08)
Plasmin Combined with Xuesaitong in the Treatment of Acute Cerebral In鄄farction
GUO Hao-zhan1, LI Hong-yuan2, XIA Dong-ya3
1.Department of Internal Neurology, Yongcheng City People's Hospital of Henan, Yongcheng, Henan Province, 476600 China;2.Department of Gastroenterology, Yongcheng City People's Hospital of Henan, Yongcheng, Henan Province, 476600 China; 3.De鄄partment of Internal Medicine-Cardiovascular, Yongcheng People's Hospital of Henan, Yongcheng, Henan Province, 476600 China[Abstract]Objective To investigate the fibrinolytic enzyme joint plug with blood on treatment of acute cerebral infarction by clin鄄ical effect.Methods In April 2014 - March 2015 in our hospital for treatment of 108 patients with acute cerebral infarction were divided into observation group and control group in random way, in the control group patients choose blood plug for treatment, pa鄄tients in observation group based linked synthetic fiber dissolving enzyme treatment in the control group.Results The clinical ef鄄fective rate was 74.1% in control group and observation group of patients with clinical total effective rate can reach 92.6%; Obser鄄vation group patients before and after treatment in scoring with an average of (26.6±8.6) points, (8.6±2.4) points, control group pa鄄tients before and after treatment in the score, respectively, on average, (26.8±8.8), (14.5±3.5) mm; Observation group of patients before and after treatment degree of nerve function defect score compared with the control group obviously the better; Two groups of patients had no serious adverse reactions.Conclusion Fibrinolytic enzyme joint plug with blood on treatment of acute cerebral infarction can get ideal clinical effect, can effectively improve the patients' clinical symptoms, enhance the neural function in pa鄄tients with and without serious adverse reaction.
[Key words]Acute cerebral infarction; Plasminogen; Xuesaitong
急性脑梗死是现代临床上常见的一种脑科疾病,在老年人中较多发,在临床上有着很高的致残率及致死率,严重威胁患者生命健康,因此,选择一种有效方法对该疾病进行治疗有着十分重要的作用及意义。……
